TD Waterhouse Canada’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
47,342
+6,237
+15% +$1.34M 0.03% 256
2026
Q1
$8.32M Buy
41,105
+12,256
+42% +$2.54M 0.02% 302
2025
Q4
$5.93M Sell
28,849
-908
-3% -$181K 0.04% 256
2025
Q3
$5.5M Sell
29,757
-4,865
-14% -$829K 0.04% 262
2025
Q2
$5.61M Sell
34,622
-2,098
-6% -$334K 0.04% 259
2025
Q1
$6.04M Sell
36,720
-592
-2% -$103K 0.05% 234
2024
Q4
$6.17M Buy
37,312
+6,578
+21% +$1.12M 0.05% 235
2024
Q3
$5.28M Sell
30,734
-40
-0.1% -$6.62K 0.04% 250
2024
Q2
$4.72M Sell
30,774
-368
-1% -$55.2K 0.04% 249
2024
Q1
$4.93M Buy
+31,142
New +$4.75M 0.04% 254

Other funds holding FBT

TD Waterhouse Canada's FBT Position: Q2 2026 in Review

TD Waterhouse Canada increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 15% in Q2 2026, buying an estimated $1.34M and bringing the position to 47,342 shares worth $11.8M. The position accounts for 0.03% of the portfolio, ranked #256.

TD Waterhouse Canada first reported a position in FBT in Q1 2024 and has held it in 10 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • TD Waterhouse Canada held 47,342 shares of First Trust NYSE Arca Biotechnology Index Fund worth $11.8M as of Q2 2026.
  • TD Waterhouse Canada bought 6,237 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.34M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of TD Waterhouse Canada's portfolio in Q2 2026, its #256 holding.
  • TD Waterhouse Canada first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2024 and has held it in 10 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.